0001171843-21-001809.txt : 20210316 0001171843-21-001809.hdr.sgml : 20210316 20210316070017 ACCESSION NUMBER: 0001171843-21-001809 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210312 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20210316 DATE AS OF CHANGE: 20210316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 21743594 BUSINESS ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 f8k_031621.htm FORM 8-K
0001629137 false 0001629137 2021-03-12 2021-03-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 12, 2021

 

 

 

GLOBAL BLOOD THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

         
Delaware   001-37539   27-4825712

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

181 Oyster Point Blvd.

South San Francisco, California

  94080
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (650) 741-7700

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

         
Title of each class  

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001 per share   GBT   The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On March 12, 2021, Global Blood Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a license agreement (the “License Agreement”) with Sanofi, a French corporation (“Sanofi”), pursuant to which Sanofi granted the Company an exclusive and sublicensable license under certain patent rights and know-how controlled by Sanofi to use, develop, manufacture, commercialize and otherwise exploit certain compounds, including compounds directed against or that modulate one of two specified targets (the “Licensed Compounds”) and any product containing a Licensed Compound (the “Licensed Products”) for the diagnosis, prevention and/or treatment of human diseases (the “Field”) worldwide. Sanofi retains rights to use its know-how to conduct non-clinical development of, and to manufacture, compounds other than the Licensed Compounds or the Licensed Products.

 

In consideration for the license grant, the Company agreed to pay Sanofi (i) an upfront cash payment of $2.25 million payable within 10 business days of the execution date of the License Agreement and (ii) up to an aggregate of $351.0 million in milestone payments upon the achievement of certain development, regulatory, commercial and sales-based milestones relating to the Licensed Products.

 

The Company also agreed to pay Sanofi royalties in the low single-digit to mid-single-digit percentages of annual net sales of Licensed Products. The royalties are payable on a Licensed Product-by-Licensed Product and country-by-country basis commencing on the first commercial sale of a Licensed Product in such country and continuing until the latest of (i) ten years after the first commercial sale of such Licensed Product in such country, (ii) the expiration of the last valid claim under the licensed patent rights or certain derived patent rights that cover such Licensed Product in such country, and (iii) the expiration of regulatory exclusivity for such Licensed Product in such country (collectively, the “Royalty Term”). The royalty rate is subject to reduction under certain circumstances.

 

The Company is solely responsible, at its own expense, for all development, manufacturing, regulatory activities and commercialization of the Licensed Products in the Field worldwide. Under the License Agreement, the Company has agreed to use commercially reasonable efforts to develop, obtain regulatory approval for and commercialize one or more Licensed Products in certain territories.

 

The License Agreement will expire on a Licensed Product-by-Licensed Product and country-by-country basis on the date of the expiration of all applicable Royalty Terms, unless earlier terminated. Upon expiration of the License Agreement with respect to a Licensed Product and country, the Company’s license with respect to the applicable Licensed Product in the applicable country will become a fully paid-up, perpetual and irrevocable license. Either party may terminate the License Agreement for the other party’s material breach following a cure period or upon certain insolvency events. The Company may terminate the License Agreement, for any or no reason, upon 90 days’ prior written notice to Sanofi, and Sanofi may terminate the License Agreement in the event the Company challenges the validity or enforceability of Sanofi’s patent rights. Upon any termination of the License Agreement before its expiration, all rights and licenses granted by Sanofi to the Company under the License Agreement or with respect to the specific terminated Licensed Product, as applicable, will terminate and revert to Sanofi.

 

The License Agreement contains, among other provisions, customary representations and warranties, covenants, indemnification obligations and confidentiality provisions for a transaction of this nature.

 

The foregoing description of the License Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the License Agreement, which the Company intends to file, with confidential terms redacted, as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarterly period ending March 31, 2021.

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

             
        GLOBAL BLOOD THERAPEUTICS, INC.
       
Date: March 16, 2021       By:  

/s/ Jeffrey Farrow

            Jeffrey Farrow
            Chief Financial Officer

 

 

 

EX-101.SCH 2 gbt-20210312.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 gbt-20210312_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 gbt-20210312_pre.xml XBRL PRESENTATION FILE XML 5 f8k_031621_htm.xml IDEA: XBRL DOCUMENT 0001629137 2021-03-12 2021-03-12 iso4217:USD shares iso4217:USD shares 0001629137 false 8-K 2021-03-12 GLOBAL BLOOD THERAPEUTICS, INC. DE 001-37539 27-4825712 181 Oyster Point Blvd. South San Francisco CA 94080 (650) 741-7700 false false false false Common Stock, par value $0.001 per share GBT NASDAQ false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover
Mar. 12, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 12, 2021
Entity File Number 001-37539
Entity Registrant Name GLOBAL BLOOD THERAPEUTICS, INC.
Entity Central Index Key 0001629137
Entity Tax Identification Number 27-4825712
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 181 Oyster Point Blvd.
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code (650)
Local Phone Number 741-7700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol GBT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://gbt.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_031621.htm gbt-20210312.xsd gbt-20210312_lab.xml gbt-20210312_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f8k_031621.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "f8k_031621.htm" ] }, "labelLink": { "local": [ "gbt-20210312_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "gbt-20210312_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "gbt-20210312.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "GBT", "nsuri": "http://gbt.com/20210312", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "f8k_031621.htm", "contextRef": "From2021-03-12to2021-03-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://gbt.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "f8k_031621.htm", "contextRef": "From2021-03-12to2021-03-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://gbt.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 13 0001171843-21-001809-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-21-001809-xbrl.zip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end